Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

5927 ARTíCULOS , VIENDO DEL 121 AL 135

PUBMED

Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes

Lisco G, De Tullio A, Iovino M, Disoteo O, Guastamacchia E, Giagulli VA, Triggiani V.

Biomedicines. 2023 Nov 7;11(11):2993. doi: 10.3390/biomedicines11112993.

0

0

0

PUBMED

Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study

Cheng YF, Liu KC, Yang TM, Xiao Y, Jiang QR, Huang JX, Zhang S, Wei QQ, Ou RW, Li CY, Gu XJ, Burgunder JM, Shang HF.

Brain Behav. 2023 Nov;13(11):e3258. doi: 10.1002/brb3.3258. Epub 2023 Oct 17.

0

0

0

PUBMED

A meta-analysis of differentially expressed and regulatory genes with their functional enrichment analysis for brain transcriptome data in autism spectrum disorder

Trivedi P, Pandey M, Kumar Rai P, Singh P, Srivastava P.

J Biomol Struct Dyn. 2023 Nov;41(19):9382-9388. doi: 10.1080/07391102.2022.2143900. Epub 2022 Nov 14.

0

0

0

PUBMED

Particulate matter exposure and neurodegenerative diseases: A comprehensive update on toxicity and mechanisms

Lee J, Weerasinghe-Mudiyanselage PDE, Kim B, Kang S, Kim JS, Moon C.

Ecotoxicol Environ Saf. 2023 Nov 1;266:115565. doi: 10.1016/j.ecoenv.2023.115565. Epub 2023 Oct 11.

0

0

0

PUBMED

Plasma GFAP and its association with disease severity in Huntington's disease

Tan K, Alpaugh M, Ashton NJ, Chouinard S, Barker RA, Blennow K, Zetterberg H, Cicchetti F, Benedet AL.

J Neurol. 2023 Nov 18. doi: 10.1007/s00415-023-12109-y. Online ahead of print.

0

0

0

PUBMED

Putative role of immune reactions in the mechanism of tardive dyskinesia

Loonen AJM.

Brain Behav Immun Health. 2023 Sep 23;33:100687. doi: 10.1016/j.bbih.2023.100687. eCollection 2023 Nov.

0

0

0

PUBMED

Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease

O'Reilly D, Belgrad J, Ferguson C, Summers A, Sapp E, McHugh C, Mathews E, Boudi A, Buchwald J, Ly S, Moreno D, Furgal R, Luu E, Kennedy Z, Hariharan V, Monopoli K, Yang XW, Carroll J, DiFiglia M, Aro

Mol Ther. 2023 Nov 1;31(11):3355-3356. doi: 10.1016/j.ymthe.2023.09.016. Epub 2023 Sep 25.

0

0

0

PUBMED

Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders

Yasamineh S, Mehrabani FJ, Derafsh E, Danihiel Cosimi R, Forood AMK, Soltani S, Hadi M, Gholizadeh O.

Mol Neurobiol. 2023 Nov 23. doi: 10.1007/s12035-023-03798-7. Online ahead of print.

0

0

0

PUBMED

Aberrant splicing in Huntington's disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification

Nguyen TB, Miramontes R, Chillon-Marinas C, Maimon R, Vazquez-Sanchez S, Lau AL, McClure NR, England WE, Singha M, Stocksdale JT, Jang KH, Jung S, McKnight JI, Ho LN, Faull RLM, Steffan JS, Reidling J

bioRxiv. 2023 Nov 2:2023.10.31.565004. doi: 10.1101/2023.10.31.565004. Preprint.

0

0

0

PUBMED

Author Correction: Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease

Wilton DK, Mastro K, Heller MD, Gergits FW, Willing CR, Fahey JB, Frouin A, Daggett A, Gu X, Kim YA, Faull RLM, Jayadev S, Yednock T, Yang XW, Stevens B.

Nat Med. 2023 Nov;29(11):2958. doi: 10.1038/s41591-023-02663-3.

0

0

0

PUBMED

Microtubule stabilising peptides: new paradigm towards management of neuronal disorders

Bhargava S, Kulkarni R, Dewangan B, Kulkarni N, Jiaswar C, Kumar K, Kumar A, Bodhe PR, Kumar H, Sahu B.

RSC Med Chem. 2023 Aug 14;14(11):2192-2205. doi: 10.1039/d3md00012e. eCollection 2023 Nov 15.

0

0

0

PUBMED

Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access

Giovannelli L, Bari E, Jommi C, Tartara F, Armocida D, Garbossa D, Cofano F, Torre ML, Segale L.

Bioact Mater. 2023 Jun 28;29:16-35. doi: 10.1016/j.bioactmat.2023.06.013. eCollection 2023 Nov.

0

0

0

PUBMED

Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases

Rani N, Alam MM, Jamal A, Bin Ghaffar U, Parvez S.

Ageing Res Rev. 2023 Nov;91:102036. doi: 10.1016/j.arr.2023.102036. Epub 2023 Aug 19.

0

0

0

PUBMED

Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders

Gupta R, Advani D, Yadav D, Ambasta RK, Kumar P.

Mol Neurobiol. 2023 Nov;60(11):6476-6529. doi: 10.1007/s12035-023-03502-9. Epub 2023 Jul 17.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy